The fourth wave of coronavirus infections is seen in Spain, where the number of cases reached their highest level by the end of February.
Spain’s health ministry announced 10,4744 new infections on Wednesday, bringing the total to 3.99 million, one of the most powerful countries in Europe.
“We are seeing a growing trend, a slow but steady rate of growth,” the Spanish newspaper El Pais quoted Health Minister Carolina Darius as saying on Wednesday.
The death toll in Spain also rose to 131 on Wednesday, bringing the total to 76,7566, according to figures from the health ministry.
The latest figures mean that for the first time in almost two months, there are more than 200 cases per 100,000 people. But during the worrying development, this rate Still below the January top of 900.
Caseloads increase in most areas
According to El Pais, infection rates are currently rising in all but a handful of regions of Spain, including the Canary and Balearic Islands, Valencia, Galicia and Marcia.
In the central region of the Spanish capital, Madrid, the 14-day rising case rate now stands at 377 per 100,000 people, the newspaper reported.
Madrid has consistently tried to take loose measures to infect the virus than the rest of Spain, and has kept bars and restaurants open since last summer.
The rate of infection is highest in the northern Nevar, where the number stands at 433 cases per 100,000 people per 14 days, El Pais said. Only the Spanish cities of Ceuta and Melilla in North Africa have registered worse numbers.
The increase in infections has put pressure on all hospitals in Spain, where one of the five beds in the intensive care unit is currently occupied by Covid-19 patients, El Pais said.
Darius called on Spanish regions to take preventive measures to control the outbreak, such as banning bars and restaurants to serve customers inside the home.
Mass vaccine drive
Darius added on Wednesday that despite global concerns over the Johnson & Johnson shot – Spain was confident it would be able to maintain its coronavirus vaccine targets – and that delays have resulted.
Johnson & Johnson vaccines, such as AstraZeneca Jab, have been shown to cause blood clots as a rare side effect.
Early distribution in the early second quarter of the ৫০ 500 million produced in European Union countries by Pfizer and Bioentech vaccines partially allayed suspicions caused by the suspension due to Johnson & Johnson’s single-dose vaccine in the United States.
Spain will receive four to five million more doses of the Pfizer vaccine than expected in the second quarter.
Johnson & Johnson’s dosage in Spain received initial impetus on Wednesday, with the health ministry saying stocks would be set aside next week for new guidance from the European Medicines Agency.
Darius echoed earlier remarks by Industries Minister Reyes Maroto, who remained optimistic about vaccinating 70 percent of people by the end of the summer – a level that is seen as helping to boost animal immunity.
Spain aims to fully inoculate 47 million people by the end of July. About 6..7 percent have been completely inoculated so far.
Amid the rise in infections across the country, mass immunization programs have become increasingly urgent.